Literature DB >> 17307549

Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.

Anita N Haggstrom, Beth A Drolet, Eulalia Baselga, Sarah L Chamlin, Maria C Garzon, Kimberly A Horii, Anne W Lucky, Anthony J Mancini, Denise W Metry, Brandon Newell, Amy J Nopper, Ilona J Frieden.   

Abstract

OBJECTIVES: To characterize demographic, prenatal, and perinatal features of patients with infantile hemangiomas and to determine the importance of these factors in predicting rates of complication and treatment. STUDY
DESIGN: We conducted a prospective study at 7 U.S. pediatric dermatology clinics. A consecutive sample of 1058 children, aged 12 years and younger, with infantile hemangiomas was enrolled between September 2002 and October 2003. A standardized questionnaire was used to collect demographic, prenatal, perinatal, and hemangioma-specific data. National Vital Statistic System Data (NVSS) was used to compare demographic variables and relevant rates of prenatal events.
RESULTS: In comparison with the 2002 United States National Vital Statistics System birth data, we found that infants with hemangiomas were more likely to be female, white non-Hispanic, premature (P < .0001) and the product of a multiple gestation (10.6% versus 3.1%; P < .001). Maternal age was significantly higher (P < .0001), and placenta previa (3.1%) and pre-eclampsia (11.8%) were more common.
CONCLUSIONS: Infants with hemangiomas are more likely to be female, white non-Hispanic, premature, and products of multiple gestations. Prenatal associations include older maternal age, placenta previa, and pre-eclampsia. No demographic, prenatal, and perinatal factors predicted higher rates of complications or need for treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17307549     DOI: 10.1016/j.jpeds.2006.12.003

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  85 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

2.  Incidence and clinical characteristics of periocular infantile hemangiomas.

Authors:  Saba T Alniemi; Gregory J Griepentrog; Nancy Diehl; Brian G Mohney
Journal:  Arch Ophthalmol       Date:  2012-07

Review 3.  Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Authors:  Chelsey J Forbess Smith; Sheila Fallon Friedlander; Monica Guma; Arthur Kavanaugh; Christina D Chambers
Journal:  Birth Defects Res       Date:  2017-04-12       Impact factor: 2.344

4.  Infantile hemangiomas: A review.

Authors:  Alison B Callahan; Michael K Yoon
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

5.  Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants.

Authors:  Giovanni Frongia; Ji-Oun Byeon; Raoul Arnold; Arianeb Mehrabi; Patrick Günther
Journal:  World J Pediatr       Date:  2018-05-23       Impact factor: 2.764

6.  X Chromosome-Inactivation Patterns in 31 Individuals with PHACE Syndrome.

Authors:  C T Sullivan; S L Christian; J T C Shieh; D Metry; F Blei; A Krol; B A Drolet; I J Frieden; W B Dobyns; D H Siegel
Journal:  Mol Syndromol       Date:  2012-11-16

7.  Embolization in the head and neck.

Authors:  Daniel Cooke; Basavaraj Ghodke; Sabareesh Kumar Natarajan; Danial Hallam
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

8.  Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.

Authors:  Joy Wan; Jack Steiner; Eulalia Baselga; Francine Blei; Maria Cordisco; Maria C Garzon; Deborah S Goddard; Anita Haggstrom; Alfons Krol; Ilona J Frieden; Denise Metry; Kimberly D Morel; Judith M A Verhagen; Orli Wargon; Beth A Drolet; Dawn H Siegel
Journal:  J Pediatr       Date:  2017-09-01       Impact factor: 4.406

9.  Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Authors:  Katelyn R Anderson; Jennifer J Schoch; Christine M Lohse; Jennifer L Hand; Dawn M Davis; Megha M Tollefson
Journal:  J Am Acad Dermatol       Date:  2015-10-19       Impact factor: 11.527

Review 10.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.